Loss of Transfected Human Brain Micro-Vascular Endothelial Cell Integrity during Herpes Simplex Virus Infection

Intervirology

Volumn 61, Issue 4, 2018, Pages 193-203

  Lee, Sau Har ^a,b   Atiya, Nadia ^b   Wang, Seok Mui ^d   Manikam, Rishya ^c   Raju, Chandramathi Samudi ^b   Sekaran, Shamala Devi ^e  

^a TAYLOR S UNIVERSITY   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^d UNIVERSITI TEKNOLOGI MARA   (Malaysia)

^e MAHSA Universi ty   (Malaysia)

Author keywords

Blood brain barrier; Capacitance; Electrical cell substrate impedance sensing; Herpes simplex virus; Resistance; Viral encephalitis

Indexed keywords

ARTICLE; BLOOD BRAIN BARRIER; CELL ADHESION; CELL LOSS; CELL STRUCTURE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN ALPHAHERPESVIRUS 1; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; TRANSFECTED CELL LINE; VASCULAR ENDOTHELIAL CELL; VIRUS ENCEPHALITIS; BIOLOGICAL MODEL; CELL SURVIVAL; ENDOTHELIUM CELL; GROWTH, DEVELOPMENT AND AGING; IMPEDANCE; PHYSIOLOGY; SIMPLEXVIRUS; VIROLOGY;

BLOOD-BRAIN BARRIER; CELL SURVIVAL; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; HUMANS; MODELS, BIOLOGICAL; SIMPLEXVIRUS;

EID: 85058789076     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000495180     Document Type: Article

References (25)

1. Granerod J, Crowcroft NS. The epidemiology of acute encephalitis. Neuropsychol Rehabil. 2007 Aug-Oct; 17(4-5): 406-28.
2. Spindler KR, Hsu TH. Viral disruption of the blood-brain barrier. Trends Microbiol. 2012 Jun; 20(6): 282-90.
3. Kanwar JR, Sriramoju B, Kanwar RK. Neurological disorders and therapeutics targeted to surmount the blood-brain barrier. Int J Nanomedicine. 2012; 7: 3259-78.
4. Dolan A, Jamieson FE, Cunningham C, Barnett BC, McGeoch DJ. The genome sequence of herpes simplex virus type 2. J Virol. 1998 Mar; 72(3): 2010-21.
5. Norberg P, Kasubi MJ, Haarr L, Bergstrom T, Liljeqvist JA. Divergence and recombination of clinical herpes simplex virus type 2 isolates. J Virol. 2007 Dec; 81(23): 13158-67.
6. Rigamonti A, Lauria G, Mantero V, Salmaggi A. A case of late herpes simplex encephalitis relapse. J Clin Virol. 2013 Sep; 58(1): 269-70.
7. Koyuncu OO, Hogue IB, Enquist LW. Virus infections in the nervous system. Cell Host Microbe. 2013 Apr; 13(4): 379-93.
8. van den Pol AN. Viral infection leading to brain dysfunction: more prevalent than appreciated? Neuron. 2009 Oct; 64(1): 17-20.
9. Stolwijk JA, Matrougui K, Renken CW, Trebak M. Impedance analysis of GPCR-mediated changes in endothelial barrier function: overview and fundamental considerations for stable and reproducible measurements. Pflugers Arch. 2015 Oct; 467(10): 2193-218.
10. Szulcek R, Bogaard HJ, van Nieuw Amerongen GP. Electric cell-substrate impedance sensing for the quantification of endothelial proliferation, barrier function, and motility. J Vis Exp. 2014 Mar;(85). https://doi.org/10.3791/51300.
11. Man S, Ubogu EE, Williams KA, Tucky B, Callahan MK, Ransohoff RM. Human brain microvascular endothelial cells and umbilical vein endothelial cells differentially facilitate leukocyte recruitment and utilize chemokines for T cell migration. Clin Dev Immunol. 2008; 2008: 384982.
12. Yosef N, Ubogu EE. An immortalized human blood-nerve barrier endothelial cell line for in vitro permeability studies. Cell Mol Neurobiol. 2013 Mar; 33(2): 175-86.
13. Tan WC, Jaganath IB, Manikam R, Sekaran SD. Evaluation of antiviral activities of four local Malaysian Phyllanthus species against herpes simplex viruses and possible antiviral target. Int J Med Sci. 2013 Oct; 10(13): 1817-29.
14. Blakeney S, Kowalski J, Tummolo D, DeStefano J, Cooper D, Guo M, et al. Herpes simplex virus type 2 UL24 gene is a virulence determinant in murine and guinea pig disease models. J Virol. 2005 Aug; 79(16): 10498-506.
15. Dedera D, Ratner L. Demonstration of two distinct cytopathic effects with syncytium formation-defective human immunodeficiency virus type 1 mutants. J Virol. 1991 Nov; 65(11): 6129-36.
16. Wegener J, Keese CR, Giaever I. Electric cellsubstrate impedance sensing (ECIS) as a noninvasive means to monitor the kinetics of cell spreading to artificial surfaces. Exp Cell Res. 2000 Aug; 259(1): 158-66.
17. Abbott NJ. Blood-brain barrier structure and function and the challenges for CNS drug delivery. J Inherit Metab Dis. 2013 May; 36(3): 437-49.
18. Berger JR, Houff S. Neurological complications of herpes simplex virus type 2 infection. Arch Neurol. 2008 May; 65(5): 596-600.
19. Cunningham AL, Diefenbach RJ, Miranda-Saksena M, Bosnjak L, Kim M, Jones C, et al. The cycle of human herpes simplex virus infection: virus transport and immune control. J Infect Dis. 2006 Sep; 194(s1 Suppl 1):S11-8.
20. Jacobs A, Breakefield XO, Fraefel C. HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis. Neoplasia. 1999 Nov; 1(5): 387-401.
21. Sellner J, Simon F, Meyding-Lamade U, Leib SL. Herpes-simplex virus encephalitis is characterized by an early MMP-9 increase and collagen type IV degradation. Brain Res. 2006 Dec; 1125(1): 155-62.
22. Melchjorsen J, Siren J, Julkunen I, Paludan SR, Matikainen S. Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-kappaB and IRF-3. J Gen Virol. 2006 May; 87(Pt 5): 1099-108.
23. Durmanova V, Sapak M, Kosovsky J, Rezuchova I, Kudelova M, Buc M, et al. Immune response and cytokine production following immunization with experimental herpes simplex virus 1 (HSV-1) vaccines. Folia Microbiol (Praha). 2008; 53(1): 73-83.
24. Schachtele SJ, Hu S, Little MR, Lokensgard JR. Herpes simplex virus induces neural oxidative damage via microglial cell Toll-like receptor-2. J Neuroinflammation. 2010 Jun; 7(1): 35.
25. Kavouras JH, Prandovszky E, Valyi-Nagy K, Kovacs SK, Tiwari V, Kovacs M, et al. Herpes simplex virus type 1 infection induces oxidative stress and the release of bioactive lipid peroxidation by-products in mouse P19N neural cell cultures. J Neurovirol. 2007 Oct; 13(5): 416-25.